Skip to main content

Table 2 Significantly differentially expressed genes in young endurance athletes as compared with non-athlete controls

From: Immune adaptation to chronic intense exercise training: new microarray evidence

Gene Symbol

FC

ibmt p-value

FDR

Gene Description

SNORD14E

2.00

2.02E-05

2.02E-02

small nucleolar RNA, C/D box 14E

CKS2

1.82

4.56E-06

1.65E-02

CDC28 protein kinase regulatory subunit 2

SNORD4B

1.74

3.89E-06

1.65E-02

small nucleolar RNA, C/D box 4B

HLA-DPB1

1.58

4.40E-05

2.29E-02

major histocompatibility complex, class II, DP beta 1

ATP5G1

1.53

3.28E-05

2.02E-02

ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1

DDT

1.51

6.90E-05

3.09E-02

D-dopachrome tautomerase

TMEM141

1.51

3.71E-05

2.13E-02

transmembrane protein 141

BST2

1.50

1.39E-04

3.85E-02

bone marrow stromal cell antigen 2

LSM3

1.49

2.79E-05

2.02E-02

LSM3 homolog, U6 small nuclear RNA associated (S. cerevisiae)

COX7B

1.49

1.35E-04

3.78E-02

cytochrome c oxidase subunit VIIb

RPL10A

1.49

1.12E-04

3.78E-02

ribosomal protein L10a

RPL21

1.46

9.21E-05

3.74E-02

ribosomal protein L21

HNRNPC

1.45

2.48E-05

2.02E-02

heterogeneous nuclear ribonucleoprotein C (C1/C2)

MLLT4

1.45

1.77E-04

4.46E-02

myeloid/lymphoid or mixed-lineage leukemia

RPS27

1.44

1.12E-04

3.78E-02

ribosomal protein S27

RPS19

1.43

2.29E-04

4.70E-02

ribosomal protein S19

MRPL51

1.42

4.08E-05

2.20E-02

mitochondrial ribosomal protein L51

FASTKD3

1.42

2.00E-04

4.52E-02

FAST kinase domains 3

RPLP0

1.41

2.17E-04

4.69E-02

ribosomal protein, large, P0

MIR15B

1.41

1.89E-04

4.46E-02

microRNA 15b

UQCR10

1.41

1.10E-06

1.15E-02

ubiquinol-cytochrome c reductase, complex III subunit X

RAB33A

1.40

5.50E-06

1.65E-02

RAB33A, member RAS oncogene family

RPL23

1.40

6.30E-05

2.96E-02

ribosomal protein L23

EDF1

1.40

3.02E-05

2.02E-02

endothelial differentiation-related factor 1

RPL36A

1.40

2.25E-04

4.70E-02

ribosomal protein L36a

RPL31

1.38

1.31E-04

3.78E-02

ribosomal protein L31

RPS18P9

1.38

1.29E-04

3.78E-02

ribosomal protein S18 pseudogene 9

CD79B

1.38

2.72E-05

2.02E-02

CD79b molecule, immunoglobulin-associated beta

RPL6

1.37

6.25E-06

1.65E-02

ribosomal protein L6

SEC61G

1.37

1.08E-04

3.78E-02

Sec61 gamma subunit

SF3B5

1.37

8.80E-06

1.65E-02

splicing factor 3b, subunit 5, 10 kDa

TPI1

1.37

8.13E-06

1.65E-02

triosephosphate isomerase 1

MRPL28

1.37

2.08E-06

1.15E-02

mitochondrial ribosomal protein L28

ACOT13

1.36

2.26E-05

2.02E-02

acyl-CoA thioesterase 13

SNHG12

1.35

2.28E-04

4.70E-02

small nucleolar RNA host gene 12 (non-protein coding)

C15orf57

1.35

3.05E-05

2.02E-02

chromosome 15 open reading frame 57

BEX4

1.35

1.24E-04

3.78E-02

brain expressed, X-linked 4

TMEM223

1.34

9.57E-05

3.74E-02

transmembrane protein 223

PSMG3

1.34

1.12E-05

1.65E-02

proteasome (prosome, macropain) assembly chaperone 3

MZT2A

1.34

2.25E-04

4.70E-02

mitotic spindle organizing protein 2A

LIPT1

1.34

9.42E-05

3.74E-02

lipoyltransferase 1

ATP5J

1.33

1.93E-06

1.15E-02

ATP synthase, H+ transporting, mitochondrial Fo complex

HSF5

1.33

1.32E-04

3.78E-02

heat shock transcription factor family member 5

CCDC72

1.33

3.52E-05

2.11E-02

coiled-coil domain containing 72

RPP21

1.32

8.65E-05

3.69E-02

ribonuclease P/MRP 21 kDa subunit

THYN1

1.32

1.09E-05

1.65E-02

thymocyte nuclear protein 1

SNRPG

1.32

1.17E-04

3.78E-02

small nuclear ribonucleoprotein polypeptide G

C1orf220

1.32

1.20E-04

3.78E-02

chromosome 1 open reading frame 220

SSBP2

1.31

3.20E-05

2.02E-02

single-stranded DNA binding protein 2

DPY30

1.31

1.10E-05

1.65E-02

dpy-30 homolog (C. elegans)

COX4I1

1.31

1.89E-06

1.15E-02

cytochrome c oxidase subunit IV isoform 1

C14orf2

1.31

8.66E-05

3.69E-02

chromosome 14 open reading frame 2

C13orf27

1.30

6.09E-05

2.96E-02

chromosome 13 open reading frame 27

C6orf226

1.30

1.89E-04

4.46E-02

chromosome 6 open reading frame 226

NDUFA12

1.30

6.42E-05

2.96E-02

NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12

MRPS11

1.30

2.28E-05

2.02E-02

mitochondrial ribosomal protein S11

CCDC56

1.30

2.05E-05

2.02E-02

coiled-coil domain containing 56

NDUFA2

1.30

1.77E-04

4.46E-02

NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8 kDa

PFDN1

1.30

1.82E-04

4.46E-02

prefoldin subunit 1

PDE6D

1.30

2.69E-05

2.02E-02

phosphodiesterase 6D, cGMP-specific, rod, delta

SENP1

1.29

6.98E-05

3.09E-02

SUMO1/sentrin specific peptidase 1

MIF

1.28

2.72E-05

2.02E-02

macrophage migration inhibitory factor

NCRNA00188

1.28

1.34E-04

3.78E-02

non-protein coding RNA 188

MRPS33

1.28

1.98E-04

4.52E-02

mitochondrial ribosomal protein S33

IFI27L2

1.27

9.80E-05

3.74E-02

interferon, alpha-inducible protein 27-like 2

ATP5H

1.27

3.10E-05

2.02E-02

ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d

ZNF140

1.27

3.84E-05

2.13E-02

zinc finger protein 140

ATP5F1

1.27

2.29E-05

2.02E-02

ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1

SKP2

1.26

1.04E-04

3.78E-02

S-phase kinase-associated protein 2 (p45)

ZNF786

1.25

2.57E-05

2.02E-02

zinc finger protein 786

TUBB4Q

0.78

1.41E-04

3.85E-02

tubulin, beta polypeptide 4, member Q

PIM2

0.74

2.42E-04

4.91E-02

pim-2 oncogene

  1. Significantly differentially expressed genes having a false discovery rates (FDRs, significance statistic adjusted for multiple testing) of ≤0.05 from an intensity-based Bayesian moderated t-test (IBMT) are shown. FC, fold change, calculated as the ratio of mRNA levels (athletes/controls)